Zealand Pharma
ZEAL.CO
$87.60
Share price
5.07%
Change (1 day)
156.59%
Change (1 year)
Categories
P/S ratio for Zealand Pharma (ZEAL.CO)
P/S ratio as of April 2024 (TTM): 111
According to Zealand Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 111.39. At the end of 2023 the company had a P/S ratio of 66.1.
P/S ratio history for Zealand Pharma from 2013 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 66.1 | 17.17% |
| 2022 | 56.4 | 809.23% |
| 2021 | 6.20 | 41.15% |
| 2020 | 4.40 | -85.67% |
| 2019 | 30.7 | 209.13% |
| 2018 | 9.92 | 206.22% |
| 2017 | 3.24 | 98.97% |
| 2016 | 1.63 | |
| 2014 | 1.83 | -95.22% |
| 2013 | 38.3 |